0.01Open0.01Pre Close0 Volume3.00K Open Interest21.00Strike Price0.00Turnover75.79%IV15.57%PremiumNov 22, 2024Expiry Date0.00Intrinsic Value100Multiplier4DDays to Expiry0.01Extrinsic Value100Contract SizeAmericanOptions Type-0.0142Delta0.0184Gamma2486.00Leverage Ratio-0.0068Theta0.0000Rho-35.20Eff Leverage0.0009Vega
Pfizer Stock Discussion
bottom or not?
more selling
Hugely Undervalued $2 Biotech With 21% Held Short $16 Price Target, Takeover Candidate, Soon Profitable. Fund that owns $Viking Therapeutics (VKTX.US)$ since 2022 below $10 a share is also investing in ESPR and expects the company will be a block buster.
This unique biotech $Esperion Therapeutics (ESPR.US)$ Esper...
No comment yet